The nature of activatory and tolerogenic dendritic cell-derived signal II.
about
Immunostimulatory Gene Therapy Using Oncolytic Viruses as VehiclesThe role of T and B cells in human atherosclerosis and atherothrombosisProspects of immune checkpoint modulators in the treatment of glioblastomaImpact of smoking on dendritic cell phenotypes in the airway lumen of patients with COPD.iPSC-Derived Regulatory Dendritic Cells Inhibit Allograft Rejection by Generating Alloantigen-Specific Regulatory T Cells.Glucose represses dendritic cell-induced T cell responses.Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go.Tolerogenic dendritic cells and their applications in transplantationSerotype-specific Binding Properties and Nanoparticle Characteristics Contribute to the Immunogenicity of rAAV1 VectorsComparison of cytotoxic T lymphocyte responses against pancreatic cancer induced by dendritic cells transfected with total tumor RNA and fusion hybrided with tumor cell.Recent advances and future of immunotherapy for glioblastoma.Investigations of the functional states of dendritic cells under different conditioned microenvironments by Fourier transformed infrared spectroscopy.Blood dendritic cells: "canary in the coal mine" to predict chronic inflammatory disease?Stressful presentations: mild cold stress in laboratory mice influences phenotype of dendritic cells in naïve and tumor-bearing mice.Dendritic cells: cellular mediators for immunological toleranceCrosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy.Diversity of immune cell types in multiple sclerosis and its animal model: Pathological and therapeutic implications.Human CD1c(+) DCs are critical cellular mediators of immune responses induced by immunogenic cell death.Co-stimulatory function in primary germinal center responses: CD40 and B7 are required on distinct antigen-presenting cells.Altered molecular expression of TLR-signaling pathways affects the steady-state release of IL-12p70 and IFN-α in patients with relapsing-remitting multiple sclerosis.Mining the Complex Family of Protein Tyrosine Phosphatases for Checkpoint Regulators in Immunity.Effect of immune tolerance induced by immature dendritic cells and CTLA4-Ig on systemic lupus erythematosus: An in vivo study.Primary Human Blood Dendritic Cells for Cancer Immunotherapy-Tailoring the Immune Response by Dendritic Cell Maturation.Streptococcus suis Serotype 2 Infection Impairs Interleukin-12 Production and the MHC-II-Restricted Antigen Presentation Capacity of Dendritic Cells.Dendritic Cells Actively Limit Interleukin-10 Production Under Inflammatory Conditions via DC-SCRIPT and Dual-Specificity Phosphatase 4.Tolerogenic dendritic cells suppress murine corneal allograft rejection by modulating CD28/CTLA-4 expression on regulatory T cellsThe Journey of Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road
P2860
Q26777403-61E4FA52-BBC6-40B8-B10B-1E1E6F2032A2Q27000791-2A5415B2-0CF5-45B8-89A7-FFC680C8F33CQ28081371-9AA03BCA-EC49-469B-A7DD-9546B857E760Q33613164-CABAC459-EB99-4273-87E9-F74777A64E8DQ33659263-76363D7E-D27D-40F2-B11E-5D6A2586AA0BQ33766590-7FB8788D-4A8E-43FD-A73F-5AE98502A8A2Q34658452-72D56FC3-69B2-422B-AA7F-BF126726F5CDQ36302853-08AE7339-3729-444B-8EA6-089A19EE34A4Q36756695-730B9418-47D6-48D7-988C-0028DE723D19Q37071139-0F0D5B8F-14D9-43FF-9963-7A9EFDC78F51Q37239071-376870F1-DC08-4EB2-8818-878A7C8FA1D4Q37501316-14BBC4B9-A789-4234-BC6D-180CB3C43186Q37516516-B66A3C5B-1497-4311-9557-A8A67E6E9671Q37571842-552AF3F1-703F-43C6-8566-3AAFB19B4C6AQ38114071-83019AAF-0304-4BC6-8763-5DD195FE9EBFQ38206571-3BC9A64F-FB91-476E-B3C8-C9167E37D470Q39085433-0CF534B1-83B0-408A-AB93-75A523FB0748Q39397337-F34D5199-2DE5-47F4-9313-EFDDDFE4163EQ40109543-4E1C2B80-25A6-4825-A72A-0DF1F939AD18Q40732094-F772EEBF-2090-4A25-A2D4-4BAB3F47C67CQ47774258-F89C379F-488D-4FDA-B4D3-905D7F66A62AQ49875978-E5E84AE8-E8F9-44C7-AC56-F685F8361215Q51050849-3BDB5B4B-7B1C-40EB-85E4-03DCD6C2AB43Q55488025-D6C24D1B-9935-4344-B10E-76F3E57209B9Q55514821-B680C158-DAFF-4DA5-8E9A-BFD160AC2C51Q56896805-334E5862-7281-455C-838B-44FFCC3DD1A2Q58750585-CC6F9DDD-D8DD-4164-B015-EA91D54D3EE4
P2860
The nature of activatory and tolerogenic dendritic cell-derived signal II.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The nature of activatory and tolerogenic dendritic cell-derived signal II.
@en
type
label
The nature of activatory and tolerogenic dendritic cell-derived signal II.
@en
prefLabel
The nature of activatory and tolerogenic dendritic cell-derived signal II.
@en
P2093
P2860
P356
P1476
The nature of activatory and tolerogenic dendritic cell-derived signal II.
@en
P2093
Ghaith Bakdash
I Jolanda M de Vries
Simone P Sittig
Tjeerd van Dijk
P2860
P356
10.3389/FIMMU.2013.00053
P50
P577
2013-02-28T00:00:00Z